ArticleBone & joint research2026
Vascular remodelling and fibrotic changes in the joint capsule during periprosthetic knee infections.
Article in Bone & joint research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Periprosthetic joint infection (PJI) represents one of the most severe complications following joint arthroplasty, often associated with a high recurrence rate despite appropriate therapeutic interventions. The underlying mechanisms contributing to this persistent risk remain incompletely understood. We hypothesize that alterations in joint capsule vascularization and fibrotic remodelling contribute to the pathophysiology of PJI and its recurrence. Methods: A total of 69 patients undergoing joint arthroplasty surgery were included in the study (21 controls: primary total knee arthroplasty (TKA), 22 PJI revision: explantation, and 26 PJI revision: prosthesis reimplantation after temporary arthrodesis). Each knee joint capsule specimen was analyzed using haematoxylin and eosin (HE) staining, Masson's trichrome, Sirius red staining, immunofluorescence staining, and real-time quantitative polymerase chain reaction (RT-qPCR). Results: Mean vessel area, diameter, and perimeter were reduced in PJI specimens, despite an overall increase in the number of blood vessels. A significant reduction in smooth muscle cell (SMC) and pericyte layer thickness, along with decreased pericyte coverage of vessel walls, was observed following both explantation and reimplantation. Fibrotic remodelling, indicated by increased collagen deposition, was markedly elevated in PJI samples at both stages. Gene expression analysis revealed upregulation of PDGFB, MIG, MMP-9, and COL1A1 at explantation or reimplantation, while PDGFA and FN1 were downregulated at explantation and significantly upregulated at reimplantation. VEGFA and FGF-2 expression remained consistently suppressed. Conclusion: PJI is associated with profound vascular remodelling and fibrotic transformation of the joint capsule, marked by aberrant angiogenesis, disrupted vessel architecture, and distinct gene expression profiles. These alterations may impair tissue perfusion, compromise immune surveillance, and hinder antibiotic delivery, thereby contributing to recurrent infection. Targeting soft-tissue vascularization and fibrosis may represent a novel therapeutic strategy to reduce PJI recurrence and enhance surgical outcomes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.